NexgenRx Inc.
TSX VENTURE : NXG

NexgenRx Inc.

October 12, 2007 18:24 ET

NexgenRx Provides Update Re Convertible Debenture Offering

TORONTO, ONTARIO--(Marketwire - Oct. 12, 2007) - NEXGENRX INC. (TSX VENTURE:NXG) ("NexgenRx" or the "Corporation") announces that its non-brokered offering of debentures ("Debentures") is ongoing and is expected to be completed within the next week. It is anticipated that the Debentures and Common Shares issuable upon conversion of the Debentures will be subject to a four-month hold period.

About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design, management and administration of health benefit plans offered by employers and other plan sponsors for the benefit of their employees and plan members. NexgenRx provides an efficient, cost-effective alternative for Canadian plan sponsors who provide an adminstration services only, or "ASO" health benefit plan to their plan members. NexgenRx also provides a competitive alternative for the provision of health benefit claims adjudication services to third party administrators who manage and administer benefit plans on behalf of a number of plan sponsors and whose services to such plan sponsors include, but are not limited to, the adjudication and payment of health benefit claims made under the plans managed and administered by them.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • NexgenRx Inc.
    Ronald C. Loucks
    President and CEO
    (416) 695-3393 x 801
    (647) 722-2920 (FAX)
    or
    NexgenRx Inc.
    Jeff Dawley
    VP Finance, CFO and Corporate Secretary
    (416) 695-3393 x 803
    (647) 722-2921 (FAX)